• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Corrigendum to "In vivo anti-apoptosis activity of novel berberine-loaded chitosan nanoparticles effectively ameliorates osteoarthritis" [Int. Immunopharmacol. 28(1) (2015) 34-43].

作者信息

Zhou Yan, Liu Shi-Qing, Peng Hao, Yu Ling, He Bin, Zhao Qi

机构信息

Department of Orthopedics, Central Laboratory, Renmin Hospital, Wuhan University, Wuhan 430060, China.

Department of Orthopedics, Central Laboratory, Renmin Hospital, Wuhan University, Wuhan 430060, China.

出版信息

Int Immunopharmacol. 2022 Jul;108:108844. doi: 10.1016/j.intimp.2022.108844. Epub 2022 May 11.

DOI:10.1016/j.intimp.2022.108844
PMID:35562271
Abstract
摘要

相似文献

1
Corrigendum to "In vivo anti-apoptosis activity of novel berberine-loaded chitosan nanoparticles effectively ameliorates osteoarthritis" [Int. Immunopharmacol. 28(1) (2015) 34-43].《新型载黄连素壳聚糖纳米粒的体内抗凋亡活性有效改善骨关节炎》的勘误[《国际免疫药理学》28(1)(2015)34 - 43]
Int Immunopharmacol. 2022 Jul;108:108844. doi: 10.1016/j.intimp.2022.108844. Epub 2022 May 11.
2
Corrigendum to "In vivo anti-apoptosis activity of novel berberine-loaded chitosan nanoparticles effectively ameliorates osteoarthritis" [Int. Immunopharmacol. 28(1) (2015) 34-43].《新型载黄连素壳聚糖纳米粒的体内抗凋亡活性有效改善骨关节炎》的勘误[《国际免疫药理学》28(1)(2015)34 - 43]
Int Immunopharmacol. 2020 Sep;86:106796. doi: 10.1016/j.intimp.2020.106796. Epub 2020 Jul 14.
3
In vivo anti-apoptosis activity of novel berberine-loaded chitosan nanoparticles effectively ameliorates osteoarthritis.新型载黄连素壳聚糖纳米粒的体内抗凋亡活性有效改善骨关节炎。
Int Immunopharmacol. 2015 Sep;28(1):34-43. doi: 10.1016/j.intimp.2015.05.014. Epub 2015 May 20.
4
Corrigendum to 'In-vitro and in-vivo anti-breast cancer activity of synergistic effect of berberine and exercise through promoting the apoptosis and immunomodulatory effects' [Int. Immunopharmacol. 87 (2020) 106787].《小檗碱与运动协同作用通过促进细胞凋亡和免疫调节作用的体外和体内抗乳腺癌活性》的勘误[《国际免疫药理学》87卷(2020年)106787]
Int Immunopharmacol. 2020 Nov;88:106899. doi: 10.1016/j.intimp.2020.106899. Epub 2020 Aug 19.
5
Sustained release effects of berberine-loaded chitosan microspheres on in vitro chondrocyte culture.载黄连素壳聚糖微球对体外软骨细胞培养的缓释作用
Drug Dev Ind Pharm. 2017 Oct;43(10):1703-1714. doi: 10.1080/03639045.2017.1339076. Epub 2017 Jun 26.
6
Corrigendum to "Anti-arthritis effect of berberine associated with regulating energy metabolism of macrophages through AMPK/HIF-1α pathway". [Int. Immunopharmacol. 87 (2020) 106830].《黄连素通过AMPK/HIF-1α途径调节巨噬细胞能量代谢发挥抗关节炎作用》勘误 [《国际免疫药理学》87卷(2020年)106830页]
Int Immunopharmacol. 2021 Oct;99:107911. doi: 10.1016/j.intimp.2021.107911. Epub 2021 Aug 2.
7
Corrigendum to "Berberine regulates PADI4-related macrophage function to prevent lung cancer" [Int. Immunopharmacol. 110 (2022) 108965].《小檗碱调节与PADI4相关的巨噬细胞功能以预防肺癌》的勘误 [《国际免疫药理学》110 (2022) 108965]
Int Immunopharmacol. 2023 Jul;120:110366. doi: 10.1016/j.intimp.2023.110366. Epub 2023 May 29.
8
Corrigendum to "Monotropein exerts protective effects against IL-1β-induced apoptosis and catabolic responses on osteoarthritis chondrocytes" [Int. Immunopharmacol. 23(2) (2014) 575-580].
Int Immunopharmacol. 2023 Mar;116:109633. doi: 10.1016/j.intimp.2022.109633. Epub 2023 Feb 11.
9
Corrigendum to "Berberine derivative DCZ0358 induced oxidative damage by ROS-mediated JNK signaling in DLBCL cells" [Int. Immunopharmacol. 125(Part A) (2023) 111139].对“小檗碱衍生物DCZ0358通过ROS介导的JNK信号通路在弥漫性大B细胞淋巴瘤细胞中诱导氧化损伤”[《国际免疫药理学》125(A部分)(2023)111139]的勘误
Int Immunopharmacol. 2024 Aug 20;137:112499. doi: 10.1016/j.intimp.2024.112499. Epub 2024 Jun 21.
10
Berberine Hydrochloride-Loaded Chitosan Nanoparticles Effectively Targets and Suppresses Human Nasopharyngeal Carcinoma.载盐酸小檗碱的壳聚糖纳米粒有效靶向并抑制人鼻咽癌
J Biomed Nanotechnol. 2018 Aug 1;14(8):1486-1495. doi: 10.1166/jbn.2018.2596.